1. Japan Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd.

TTSE:4928
4,740.00
JPY
+45.00
(+0.96%)
154.39BMarket Cap
Nov 10Next Earn
Noevir Holdings Co., Ltd.
TSE:4928
(Tokyo Stock Exchange)

Recent

price

4,740.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
JPY
1,272.42
594.87
1,242.83
1,242.34
1,288.72
1,381.39
1,443.66
1,536.54
1,685.32
1,734.72
1,517.75
1,501.09
1,790.09
1,831.34
1,868.56
1,894.97
- -
Revenue per Share
37.87
14.88
73.37
122.34
116.15
136.78
142.42
199.62
228.55
211.56
164.48
186.88
222.18
224.64
233.34
235.1
- -
Basic EPS, GAAP
92.88
61.31
102.96
139.17
64.66
66.77
119.35
184.96
106.67
244.02
165.85
252.66
153.18
192.41
237.53
158.39
- -
Free Cash Flow per Basic Share
35.96
0.07
39.17
40.02
50.05
62.79
99.91
119.94
154.9
179.97
199.87
205
209.8
214.92
220.22
224.94
- -
Dividend per Share
1,258.21
1,248.02
1,325.88
1,421.42
1,494.1
1,536.8
1,573.5
1,669.15
1,517.57
1,543.71
1,521.76
1,520.24
1,524.02
1,545.54
1,565.66
1,574.15
1,430.55
Book Value per Share
1,225.52
1,224.14
1,314.46
1,414.25
1,484.06
1,525.6
1,564.24
1,661.02
1,510.98
1,529.25
1,509.17
1,507.62
1,511.78
1,525.07
1,536.56
1,539.49
1,397.87
Tangible Book Value per Share
41
41
38
37
37
36
35
35
34
34
34
34
34
34
34
34
34
Basic Weighted Avg Shares
52,580
24,582
47,220
46,517
48,253
49,387
51,180
54,473
57,828
59,252
51,841
51,272
61,143
62,552
63,823
64,724
- -
Sales/Revenue/Turnover
5.29
26.18
10.91
15.59
14.65
15.37
15.06
18.34
19.62
20.25
15.56
16.7
16.55
17.63
17.9
17.12
- -
Operating Margin (%)
1,899
913
1,703
1,115
1,063
1,282
1,699
1,890
1,895
1,818
1,699
1,494
1,451
1,220
1,009
865
- -
Depreciation Expense
1,565
615
2,788
4,581
4,349
4,890
5,049
7,077
7,842
7,226
5,618
6,383
7,589
7,673
7,970
8,030
- -
Net Income, GAAP
44.4
60.51
49.33
38.88
41.54
38.99
34.88
30.57
31.76
33.62
30.99
27.95
31.41
30.84
30.38
31.06
- -
Effective Tax Rate (%)
2.98
2.5
5.9
9.85
9.01
9.9
9.87
12.99
13.56
12.2
10.84
12.45
12.41
12.27
12.49
12.41
- -
Profit Margin (%)
48,997
49,817
48,713
51,545
50,956
47,191
48,631
51,513
43,519
44,387
42,836
42,489
40,916
40,669
40,825
39,037
35,295
Working Capital
19
18
21
20
32
274
1,557
1,438
1,325
1,217
1,112
1,000
912
827
742
657
616
LT Debt
52,012
51,595
49,690
53,278
56,017
54,597
55,908
59,363
51,997
52,946
52,243
52,232
52,383
53,205
53,905
54,208
49,488
Total Equity
2.92
1.11
5.05
8.27
7.26
8.13
8.7
11.37
13.06
14.21
10.02
11.25
12.68
13.77
14.11
13.46
- -
Return on Invested Capital (%)
2.99
1.18
5.48
8.88
7.93
8.75
8.91
11.83
13.58
13.24
10.31
11.81
14.1
14.01
14.43
14.35
- -
Return on Capital (%)
3.01
1.19
5.51
8.91
7.97
8.86
9.16
12.31
14.13
13.82
10.73
12.29
14.6
14.64
15
14.98
- -
Return on Common Equity (%)

Capital Structure

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
ST Debt
86
- -
83
LT Borrowings
- -
- -
- -
LT Finance Leases
785
- -
616
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
34
Market Capitalization
178,638
156,435
154,386

Working Capital

JPY

•

in mil. unless spec.
Mar'24
Dec'26
Mar'26
Total Current Assets
48,400
- -
45,388
Cash, Cash Equivalents & STI
27,212
- -
23,423
Accounts Receivable, Net
10,512
- -
10,693
Inventories
8,560
- -
9,097
Total Current Liabilities
12,827
- -
10,093
Payables & Accruals
- -
- -
- -
ST Debt
86
- -
83
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.04%
0.74%
0.56%
Free Cash Flow
21.25%
5.74%
-33.32%
Net Income, GAAP
6.24%
7.65%
0.75%
Sales/Revenue/Turnover
3.01%
4.78%
1.41%
Total Cash Common Dividend
14.15%
2.39%
2.14%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
16,614
15,011
- -
- -
63,823
2025
- -
- -
- -
- -
64,724
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29.45
46.58
- -
- -
233.34
2025
- -
- -
- -
- -
235.1
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
217.85
2.23
- -
- -
220.22
2025
- -
- -
- -
- -
224.94
2026
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Noevir Holdings Co., Ltd. develops, manufactures and sells cosmetics, pharmaceuticals, health foods, toiletries and related products primarily in Japan with operations extending to China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States and Canada. The company's Cosmetics segment offers high-performance functional prestige skincare under the Noevir brand through face-to-face channels such as beauty salons and Group online stores; self-selection cosmetics including the Namerakahonpo skincare line, excel makeup line and NOV hypoallergenic cosmetics sold via general retailers and Group online stores; and contract manufacturing services for cosmetics and quasi-drugs on an OEM basis. The Pharmaceuticals & Health Food segment produces and markets flagship items such as Nanten Nodo Ame cough drops, functional drinks in the Min Min Da Ha lineup, over-the-counter pharmaceuticals comprising cold remedies, eye drops and digestive aids, nutritional supplements with high-quality natural ingredients and health food products including tea, distributed through drug stores, variety stores, dermatology and medical institutions as well as Noevir beauty studios and own retail stores. The Other segment engages in apparel sales, aircraft and vessel purchase/sale, aviation-related operations including air transportation and pilot training via subsidiary Noevir Aviation Co., Ltd., and leasing activities. Founded in 1964 as Noevir Co., Ltd. and established as the current holding company in 2011, Noevir Holdings is headquartered in Kobe, Japan, and listed on the Tokyo Stock Exchange Prime Market (ticker: 4928); it maintains 13 consolidated subsidiaries with 1,369 employees as of September 30, 2024. In fiscal 2025 ended September 30, 2025, the company achieved record-high net income attributable to owners of the parent at ¥8,030 million on net sales of ¥64,724 million (up 1.4% year-on-year), reflecting modest growth in the Cosmetics segment (¥50,525 million sales, up 1.5%) driven by innovation in domestic markets and brand enhancement efforts; it continues pursuing its medium- to long-term strategy of realizing steady growth through sustainability across segments, including human resource diversification, R&D/production/logistics system strengthening and adaptive management amid uncertain economic conditions with rising prices impacting consumer spending.